The 3D bioprinting market will grow at a CAGR of 15.5% by 2028

Ashapatil555017 Nov, 2022Business

Compared to non-biological printing technology, 3D bioprinting offers additional complexities such as the choice of cell types, materials, differentiation and growth factors, as well as technical issues related to living cell sensitivity, as well as organ and tissue design. Solving these complexities requires the integration of advanced technologies from the fields of biomaterials, engineering, physics, medicine and cell biology. 3D bioprinting is mainly used to create and transplant various tissues such as multi-layered bone, skin, tracheal splints, vascular grafts, cartilage structures, and heart tissue. Other notable applications are the development of high-throughput 3D bioprinted tissue models for drug discovery, toxicology, and research.